Drug Trial Radar · NCT06721962
Treatment of Moderate to Severe Refractory Crohn's Disease
Last checked: Nov 19, 2026Latest source record: Dec 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
39
Planned (sponsor's estimate)
Start
May 5, 2025
Primary completion
Jan 30, 2026
Study completion Jan 30, 2027
Sponsor
- Lead sponsor
- Tr1X, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.
Conditions
- Crohns Disease
Interventions
TRX103Biological
TRX103 is an investigational research product that may treat and provide long term relief to individuals suffering from Crohn's Disease.
CyclophosphamideDrug
Low dose cyclophosphamide conditioning.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the safety and tolerability of TRX103 infusion in subjects with moderate to severe treatment-refractory Crohn's Disease.Time frame: From baseline until 12 months post TRX103 infusion.
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Scottsdale, Arizona · Recruiting
University of California, Davis
Sacramento, California · Recruiting
University of California, San Francisco
San Francisco, California · Recruiting
University of Florida
Gainesville, Florida · Recruiting
Northwestern
Chicago, Illinois · Recruiting
University of Chicago
Chicago, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
University of Louisville
Louisville, Kentucky · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Mayo Clinic Rochester
Rochester, Minnesota · Recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
Mount Sinai Health Systems
New York, New York · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.